An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Zoetis to Participate in the Piper Sandler 35th Annual Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Zoetis Inc. (ZTS) will participate in the Piper Sandler 35th Annual Healthcare Conference on November 28, 2023. Wetteny Joseph, EVP and CFO, will represent the company. Investors can access a live webcast of the presentation on the Zoetis website.
Positive
None.
Negative
None.
PARSIPPANY, N.J.--(BUSINESS WIRE)--
Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 1:00 p.m. ET.
Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.1 billion in 2022 with approximately 13,800 employees. For more information, visit www.zoetis.com.
When will Zoetis Inc. participate in the Piper Sandler 35th Annual Healthcare Conference?
Zoetis Inc. will participate in the Piper Sandler 35th Annual Healthcare Conference on November 28, 2023.
Who will represent Zoetis Inc. at the conference?
Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent Zoetis Inc. at the conference.
How can investors access the presentation?
Investors can access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay will also be available on the Zoetis website after the event.
Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.
